Document Detail


From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.
MedLine Citation:
PMID:  23340856     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of kidney failure. It is a systemic disorder, not only affecting the kidneys, but also associated with cyst formation in other organs such as the liver, spleen, pancreas, and seminal vesicles. Other extra-renal symptoms may consist of intracranial arterial aneurysms, cardiac valvular defects, abdominal and inguinal hernias and colonic diverticulosis. Very little is known regarding bone involvement in ADPKD; however, recent evidence has revealed the potential role of fibroblast growth factor 23 (FGF23). FGF23 is an endocrine fibroblast growth factor acting in the kidney as a phosphaturic hormone and a suppressor of active vitamin D with key effects on the bone/kidney/parathyroid axis, and has been shown to increase in patients with ADPKD, even with normal renal function. The aim of this review is to provide an overview of bone and mineral abnormalities found in experimental models and in patients with ADPKD, and to discuss the possible role of FGF23 in this disease.
Authors:
Djalila Mekahli; Justine Bacchetta
Related Documents :
3185306 - Topological analysis of the three-dimensional structure of the human renal glomerulus u...
10189786 - The pathogenesis of progressive renal failure.
14611746 - The role of renal proximal tubular cells in diabetic nephropathy.
12193666 - The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome.
12717206 - Prognostic significance of free radicals: mediated injury occurring in the kidney donor.
24737576 - Acute renal failure associated with the new braf inhibitor vemurafenib: a case series o...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-24
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  -     ISSN:  1432-198X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pediatric Nephrology, University Hospital of Leuven, Herestraat 49, 3000, Leuven, Belgium, mekahli_djalila@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Should mean arterial pressure be included in the definition of ambulatory hypertension in children?
Next Document:  Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.